SCYNEXIS, Inc. Share Price
SCYXSCYNEXIS, Inc. Stock Performance
Open $3.96 | Prev. Close $4.27 | Circuit Range N/A |
Day Range $3.94 - $4.00 | Year Range $0.57 - $5.49 | Volume 584 |
Average Traded $3.96 |
SCYNEXIS, Inc. Share Price Chart
About SCYNEXIS, Inc.
SCYNEXIS, Inc., a biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States. It offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis (VVC) and recurrent VVC. The company's lead product candidate is Ibrexafungerp, a drug for the treatment of invasive candidiasis and/or candidemia, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It also develops SCY-247 to treat systemic fungal diseases. The company has licensing and collaboration agreements with GlaxoSmithKline Intellectual Property (No. 3) Limited, Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, CJSC (R-Pharm), and Cypralis Limited for the development, manufacture, and commercialization of ibrexafungerp. SCYNEXIS, Inc. was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. The company was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
SCYNEXIS, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-Jul-26 | $3.96 | $3.94 | +0.00% |
20-Jul-26 | $3.96 | $3.94 | -7.73% |
17-Jul-26 | $4.43 | $4.27 | -4.26% |
16-Jul-26 | $4.70 | $4.46 | -7.47% |
15-Jul-26 | $4.89 | $4.82 | -2.23% |
14-Jul-26 | $4.80 | $4.93 | +11.16% |
13-Jul-26 | $4.47 | $4.43 | +3.62% |
FAQs on SCYNEXIS, Inc. Share Price
Can I buy SCYNEXIS, Inc. shares in India?
What is the share price of SCYNEXIS, Inc.?
What is the 5 year returns of SCYNEXIS, Inc.?
What are the high & low stock price of SCYNEXIS, Inc. today?
What is the 52-week high and low of SCYNEXIS, Inc. stock?